Grundläggande statistik
| CIK | 45621 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Amexdrug Corporation
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| August 14, 2013 |
Quarterly Report - AMEXDRUG CORPORATION 10Q 2013-06-30 amexdrug.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-7473 |
|
| August 14, 2013 |
EX-10.6 2 amexdrugexh106.htm CHANGE IN TERMS AGREEMENT WITH NATIONAL BANK OF CALIFORNIA DATED JUNE 9, 2013 Exhibit 10.6 Principal Loan Date Maturity Loan Number Call/Coll Account Officer Initials $350,000 06-09-2013 06-09-2014 930610000 RK RK CHANGE IN TERMS AGREEMENT References in the boxes above are for Lender’s use only and do not limit the applicability of this document to any particular loan |
|
| August 14, 2013 |
EX-10.19 3 amexdrugexh1019.htm PROMISSORY NOTE WITH NATIONAL BANK OF CALIFORNIA, AMEXDRUG AND ITS SUBSIDIARIES FOR $350,000 DATED JUNE 9, 2013 Exhibit 10.19 PROMISSORY NOTE Principal Loan Date Maturity Loan Number Call/Coll Account Officer Initials $350,000 06-09-2013 06-09-2018 930819000 RK /s/RK References in the boxes above are for Lender's use only and do not limit the applicability of this do |
|
| June 26, 2013 |
- AMEXDRUG CORPORATION FORM 15 OMB Approval OMB Number: 3235-0167 Expires: December 31, 2014 Estimated average burden hours per response: 1. |
|
| May 20, 2013 |
Amexdrug AMEXDRUG CORPORATION 10Q 2013-03-31 (Quarterly Report) amexdrug.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-747 |
|
| May 16, 2013 |
- AMEXDRUG CORPORATION FORM 12B-25 SEC FILE NUMBER: 000-30239 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 3, 2013 |
Amexdrug AMEXDRUG CORPORATION FORM 10 K (Annual Report) amexdrug10k2012.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K (Mark One) (X) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2012 ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File number 0-7 |
|
| April 3, 2013 |
FIFTH AMENDMENT TO LEASE EXTENDING LEASE TERM exhibit10-13.htm Exhibit 10.13 Document Reference Date: 2/20/ 2013 Tenant Code: flalI4 Property, Building and Suite I.D.: fl2204, 2500 I / J FIFTH AMENDMENT TO LEASE EXTENDING LEASE TERM It is hereby agreed by the undersigned that the Lease dated the 23rd day of September, 2005, as amended by that certain Fifth Amendment to Lease, dated as of January 11, 2013, (collectively, the ?Lease?) by and be |
|
| April 1, 2013 |
- AMEXDRUG CORPORATION FORM 12B 25 SEC FILE NUMBER: 000-30239 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
